Labcorp wins bid to acquire select Invitae assets for $239 mln

seekingalpha04-25

Labcorp (NYSE:LH) late on Wednesday said that it has been selected as the winning bidder to acquire select assets of Invitae (OTC:NVTAQ), a medical genetics company, for $239 million. Before the ...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2430240154?lang=en_US&edition=fundamental","thumbnail":"https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1383560019/image_1383560019.jpg","is_english":true,"pubTime":"2024-04-25 15:37","share_image_url":"https://static.laohu8.com/5a36db9d73b4222bc376d24ccc48c8a4","id":"2430240154","market":"sg","top_or_hot":-1,"title":"Labcorp wins bid to acquire select Invitae assets for $239 mln","media":"seekingalpha","content":"<div>\n<p>Labcorp (NYSE:LH) late on Wednesday said that it has been selected as the winning bidder to acquire select assets of Invitae (OTC:NVTAQ), a medical genetics company, for $239 million. Before the ...</p>\n\n<a href=\"https://seekingalpha.com/news/4093807-labcorp-wins-bid-to-acquire-invitae-assets-for-239-mln\">Source Link</a>\n\n</div>\n","source":"seekingalpha","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Labcorp wins bid to acquire select Invitae assets for $239 mln</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nLabcorp wins bid to acquire select Invitae assets for $239 mln\n</h2>\n\n<h4 class=\"meta\">\n\n\n2024-04-25 15:37 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://seekingalpha.com/news/4093807-labcorp-wins-bid-to-acquire-invitae-assets-for-239-mln><strong>seekingalpha</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Labcorp (NYSE:LH) late on Wednesday said that it has been selected as the winning bidder to acquire select assets of Invitae (OTC:NVTAQ), a medical genetics company, for $239 million. Before the ...</p>\n\n<a href=\"https://seekingalpha.com/news/4093807-labcorp-wins-bid-to-acquire-invitae-assets-for-239-mln\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK4550","symbol_name":"红杉资本持仓","start_time":0,"source_url":"https://seekingalpha.com/news/4093807-labcorp-wins-bid-to-acquire-invitae-assets-for-239-mln","article_id":"2430240154","we_media_id":null,"thumbnails":["https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1383560019/image_1383560019.jpg"],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2430240154","pubTimestamp":1714030660,"sourceInfo":{"source_id":"seekingalpha","name":"Seeking Alpha"},"weMediaInfo":null,"summary":"Labcorp  late on Wednesday said that it has been selected as the winning bidder to acquire select assets of Invitae , a medical genetics company, for $239 million. Before the transaction can proceed, the court overseeing the process must issue an approval order following a hearing currently scheduled for May 6, 2024.  Upon completion, Labcorp expects this transaction would generate approximately $275-$300 million in annual revenue with the vast majority in specialty testing areas such as oncology and rare diseases. Through this transaction, anticipated to close in third quarter of 2024, Labcorp  would acquire assets being auctioned through a voluntary bankruptcy protection process. Source: Press Release    More on Laboratory Corporation of America, Invitae, etc.  Laboratory Corporation: A Healthier Diagnosis, As Pandemic Headwinds Disappear Labcorp wins FDA emergency use nod for monkeypox test","collect":0,"end_time":0,"defaultTopTitle":"seekingalpha.com","property":[],"viewcount":null,"language":"en","relate_stocks":{"BK4550":"红杉资本持仓","BK4588":"碎股","BK4196":"保健护理服务","LU0006061336.USD":"Blackrock US Small and MidCap Opportunities A2 USD","LH":"徕博科","NVTA":"Invitae Corporation","BK4585":"ETF&股票定投概念","BK4139":"生物科技"},"translate_title":"Labcorp以2.39亿美元赢得收购精选Invitae资产的竞标","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"LH":1,"NVTA":1},"content_text":"Labcorp (NYSE:LH) late on Wednesday said that it has been selected as the winning bidder to acquire select assets of Invitae (OTC:NVTAQ), a medical genetics company, for $239 million. Before the transaction can proceed, the court overseeing the process must issue an approval order following a hearing currently scheduled for May 6, 2024.  Upon completion, Labcorp expects this transaction would generate approximately $275-$300 million in annual revenue with the vast majority in specialty testing areas such as oncology and rare diseases. Through this transaction, anticipated to close in third quarter of 2024, Labcorp (LH) would acquire assets being auctioned through a voluntary bankruptcy protection process. Source: Press Release    More on Laboratory Corporation of America, Invitae, etc.  Laboratory Corporation: A Healthier Diagnosis, As Pandemic Headwinds Disappear Labcorp wins FDA emergency use nod for monkeypox test","kind":null,"is_publish_news":null,"is_publish_highlight":null,"is_publish_live":null,"is_publish_wemedia":null,"editions":null,"symbols":[],"gpt_button":1},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.22.4","shortVersion":"4.22.4","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2430240154"}